Media coverage
22
Media coverage
Title Seastar Medical Submits Investigational Device Exemption (IDE) Application To FDA To Study A Novel Therapy To Reduce Hyperinflammation In Adult Acute Kidney Injury Patients Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 9/01/23 Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients Media name/outlet Street Insider Country/Territory United States Date 9/01/23 URL https://www.streetinsider.com/Press+Releases/SeaStar+Medical+Submits+Investigational+Device+Exemption+%28IDE%29+Application+to+FDA+to+Study+a+Novel+Therapy+to+Reduce+Hyperinflammation+in+Adult+Acute+Kidney+Injury+Patients/21048656.html Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients Media name/outlet BioSpace Country/Territory United States Date 9/01/23 URL https://www.biospace.com/article/releases/seastar-medical-submits-investigational-device-exemption-ide-application-to-fda-to-study-a-novel-therapy-to-reduce-hyperinflammation-in-adult-acute-kidney-injury-patients/ Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients Media name/outlet Yahoo! News Country/Territory United States Date 9/01/23 URL https://www.yahoo.com/now/seastar-medical-submits-investigational-device-132500728.html Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients Media name/outlet ADVFN UK Country/Territory United Kingdom Date 9/01/23 URL https://uk.advfn.com/stock-market/NASDAQ/ICU/share-news/SeaStar-Medical-Submits-Investigational-Device-Exe/89937238 Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients Media name/outlet Yahoo! Sports Country/Territory United States Date 9/01/23 URL https://ca.sports.yahoo.com/news/seastar-medical-submits-investigational-device-132500728.html?src=rss Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients Media name/outlet Yahoo! Finance Country/Territory United States Date 9/01/23 URL https://finance.yahoo.com/news/seastar-medical-submits-investigational-device-132500728.html Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients Media name/outlet TD Ameritrade Country/Territory United States Date 9/01/23 URL https://research.tdameritrade.com/grid/public/markets/news/story.asp?fromPage=results&docKey=100-009u1827-1 Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients Media name/outlet Stockwatch Country/Territory Canada Date 9/01/23 URL www.stockwatch.com/News/Item/U-z8725904-U!ICU-20230109/U/ICU Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients Media name/outlet ADVFN US Country/Territory United States Date 9/01/23 URL https://www.advfn.com/p.php?pid=nmona&article=89937238 Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients Media name/outlet Spoke.com Country/Territory United States Date 9/01/23 URL https://www.spoke.com/press_releases/63bc1b29fc12b05fed0013ab Persons Kevin Chung Title Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients Media name/outlet Market News Publishing Country/Territory United States Date 9/01/23 Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients Media name/outlet GlobeNewswire Country/Territory United States Date 9/01/23 URL https://www.globenewswire.com/news-release/2023/01/09/2585240/0/en/SeaStar-Medical-Submits-Investigational-Device-Exemption-IDE-Application-to-FDA-to-Study-a-Novel-Therapy-to-Reduce-Hyperinflammation-in-Adult-Acute-Kidney-Injury-Patients.html Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients Media name/outlet PrimeNewswire (Top News) Country/Territory United States Date 9/01/23 Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Media name/outlet Jessamine Journal Country/Territory United States Date 9/01/23 URL https://smb.jessaminejournal.com/article/SeaStar-Medical-Submits-Investigational-Device-Exemption-IDE-Application-to-FDA-to-Study-a-Novel-Therapy-to-Reduce-Hyperinflammation-in-Adult-Acute-Kidney-Injury-Patients?storyId=63bc1647e21f074c81ed9c15 Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Media name/outlet Winchester Sun Country/Territory United States Date 9/01/23 URL https://smb.winchestersun.com/article/SeaStar-Medical-Submits-Investigational-Device-Exemption-IDE-Application-to-FDA-to-Study-a-Novel-Therapy-to-Reduce-Hyperinflammation-in-Adult-Acute-Kidney-Injury-Patients?storyId=63bc1647e21f074c81ed9c15 Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Media name/outlet Port Arthur News Country/Territory United States Date 9/01/23 URL https://smb.panews.com/article/SeaStar-Medical-Submits-Investigational-Device-Exemption-IDE-Application-to-FDA-to-Study-a-Novel-Therapy-to-Reduce-Hyperinflammation-in-Adult-Acute-Kidney-Injury-Patients?storyId=63bc1647e21f074c81ed9c15 Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Media name/outlet Elizabethton.com Country/Territory United States Date 9/01/23 URL https://smb.elizabethton.com/article/SeaStar-Medical-Submits-Investigational-Device-Exemption-IDE-Application-to-FDA-to-Study-a-Novel-Therapy-to-Reduce-Hyperinflammation-in-Adult-Acute-Kidney-Injury-Patients?storyId=63bc1647e21f074c81ed9c15 Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Media name/outlet Tryon Daily Bulletin Country/Territory United States Date 9/01/23 URL https://smb.tryondailybulletin.com/article/SeaStar-Medical-Submits-Investigational-Device-Exemption-IDE-Application-to-FDA-to-Study-a-Novel-Therapy-to-Reduce-Hyperinflammation-in-Adult-Acute-Kidney-Injury-Patients?storyId=63bc1647e21f074c81ed9c15 Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Media name/outlet Smithfield Times Country/Territory United States Date 9/01/23 URL https://smb.smithfieldtimes.com/article/SeaStar-Medical-Submits-Investigational-Device-Exemption-IDE-Application-to-FDA-to-Study-a-Novel-Therapy-to-Reduce-Hyperinflammation-in-Adult-Acute-Kidney-Injury-Patients?storyId=63bc1647e21f074c81ed9c15 Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Media name/outlet Suffolk News Herald Country/Territory United States Date 9/01/23 URL https://smb.suffolknewsherald.com/article/SeaStar-Medical-Submits-Investigational-Device-Exemption-IDE-Application-to-FDA-to-Study-a-Novel-Therapy-to-Reduce-Hyperinflammation-in-Adult-Acute-Kidney-Injury-Patients?storyId=63bc1647e21f074c81ed9c15 Persons Kevin Chung Title SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients Media name/outlet BizWire Express Country/Territory India Date 9/01/23 URL www.bizwireexpress.com/showstoryGNW.php?storyid=529760 Persons Kevin Chung